Literature DB >> 31267196

Epidemiology of post-influenza bacterial pneumonia due to Panton-Valentine leucocidin positive Staphylococcus aureus in intensive care units: a retrospective nationwide study.

Audrey Jacquot1, Charles-Edouard Luyt2, Antoine Kimmoun1, Bruno Levy3, Elisabeth Baux4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31267196     DOI： 10.1007/s00134-019-05665-3

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  6 in total

1.  Fatal Staphylococcus aureus haemorrhagic pneumonia producing Panton-Valentine leucocidin.

Authors:  Herve Hyvernat; Celine Pulcini; Danielle Carles; Adrien Roques; Philippe Lucas; Veronique Hofman; Paul Hofman; Gilles Bernardin
Journal:  Scand J Infect Dis       Date:  2007

2.  Prone positioning in severe acute respiratory distress syndrome.

Authors:  Claude Guérin; Jean Reignier; Jean-Christophe Richard; Pascal Beuret; Arnaud Gacouin; Thierry Boulain; Emmanuelle Mercier; Michel Badet; Alain Mercat; Olivier Baudin; Marc Clavel; Delphine Chatellier; Samir Jaber; Sylvène Rosselli; Jordi Mancebo; Michel Sirodot; Gilles Hilbert; Christian Bengler; Jack Richecoeur; Marc Gainnier; Frédérique Bayle; Gael Bourdin; Véronique Leray; Raphaele Girard; Loredana Baboi; Louis Ayzac
Journal:  N Engl J Med       Date:  2013-05-20       Impact factor: 91.245

3.  Co-infection with influenza-associated acute respiratory distress syndrome requiring extracorporeal membrane oxygenation.

Authors:  Sacha Rozencwajg; Nicolas Bréchot; Matthieu Schmidt; Guillaume Hékimian; Guillaume Lebreton; Sébastien Besset; Guillaume Franchineau; Ania Nieszkowska; Pascal Leprince; Alain Combes; Charles-Edouard Luyt
Journal:  Int J Antimicrob Agents       Date:  2017-11-21       Impact factor: 5.283

Review 4.  Pathogenesis of Staphylococcus aureus necrotizing pneumonia: the role of PVL and an influenza coinfection.

Authors:  Bettina Löffler; Silke Niemann; Christina Ehrhardt; Dagmar Horn; Christian Lanckohr; Gerard Lina; Stephan Ludwig; Georg Peters
Journal:  Expert Rev Anti Infect Ther       Date:  2013-09-27       Impact factor: 5.091

5.  Molecular characterization of Staphylococcus aureus and influenza virus coinfections in patients with fatal Pneumonia.

Authors:  Amy M Denison; Marlene Deleon-Carnes; Dianna M Blau; Eric C Shattuck; Linda K McDougal; James K Rasheed; Brandi M Limbago; Sherif R Zaki; Christopher D Paddock
Journal:  J Clin Microbiol       Date:  2013-09-25       Impact factor: 5.948

Review 6.  Secondary Bacterial Infections Associated with Influenza Pandemics.

Authors:  Denise E Morris; David W Cleary; Stuart C Clarke
Journal:  Front Microbiol       Date:  2017-06-23       Impact factor: 5.640
  6 in total
  4 in total

Review 1.  ECLS-associated infections in adults: what we know and what we don't yet know.

Authors:  Darryl Abrams; Giacomo Grasselli; Matthieu Schmidt; Thomas Mueller; Daniel Brodie
Journal:  Intensive Care Med       Date:  2019-11-25       Impact factor: 41.787

Review 2.  Methicillin-resistant Staphylococcus aureus lung infection in coronavirus disease 2019: how common?

Authors:  Matteo Bassetti; Laura Magnasco; Antonio Vena; Federica Portunato; Daniele Roberto Giacobbe
Journal:  Curr Opin Infect Dis       Date:  2022-04-01       Impact factor: 4.915

3.  Panton-Valentine Leukocidin-Secreting Staphylococcus aureus Pneumonia Complicating COVID-19.

Authors:  Claire Duployez; Rémi Le Guern; Claire Tinez; Anne-Laure Lejeune; Laurent Robriquet; Sophie Six; Caroline Loïez; Frédéric Wallet
Journal:  Emerg Infect Dis       Date:  2020-04-16       Impact factor: 6.883

4.  Prognostic factors of severe community-acquired staphylococcal pneumonia in France.

Authors:  Yves Gillet; Anne Tristan; Jean-Philippe Rasigade; Mitra Saadatian-Elahi; Coralie Bouchiat; Michele Bes; Oana Dumitrescu; Marie Leloire; Céline Dupieux; Frédéric Laurent; Gérard Lina; Jerome Etienne; Philippe Vanhems; Laurent Argaud; Francois Vandenesch
Journal:  Eur Respir J       Date:  2021-11-11       Impact factor: 16.671
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.